Hybrid Closed-Loop System Achieves Optimal Perioperative Glycemia in a Boy With Type 1 Diabetes: A Case Report

• Päätekijät: Jesus Dominguez-Riscart (Tekijä), Nuria Buero-Fernandez (Tekijä), Ana Garcia-Zarzuela (Tekijä), Fernando A. Marmolejo-Franco (Tekijä), Ana C. Perez-Guerrero (Tekijä), Alfonso M. Lechuga-Sancho (Tekijä)
• Aineistotyyppi: Kirja
• Julkaistu: Frontiers Media S.A., 2021-04-01T00:00:00Z.
• Aiheet: article
• Linkit: Connect to this object online.

The goal in type 1 diabetes (T1D) therapy is to maintain optimal glycemic control under any circumstance. Diabetes technology is in continuous development to achieve this goal. The most advanced Food and Drug Administration- and European Medicines Agency-approved devices are hybrid closed-loop (HCL)...